Willingsford presents a demonstrated safe and effective treatment for wounds in a market defined as an unmet medical need, as stated by the FDA (USA) in 2022.
Without the use of antimicrobials, Willingsford’s EU-approved technology, MPPT, consistently removes wound infections, including antimicrobial resistant infections. This is done without creating further AMR in the patient or environment - unlike most standard approaches to wound care.
Recognising the vast and complex processes involved in the many steps to healing, Willingsford has opted to work in synergy with the immune system and support its interactions with the wound microbiome.
By doing so, Willingsford has demonstrated financial savings of 64-81% per wound. Wound care, in 2022, absorbs one fifth of the health services’ overall annual budgets and seizes half of their nursing capacity.
In an age with a nurse shortage, this technology can cut the nursing capacity currently spent on wounds by three quarters. As the wounds demonstrably close, they do not require as many dressing changes, and the CO2 emissions associated with transport to and from the location of dressing changes also reduce by 75%. Calculations actually show that the reduction in CO2 is 89%.
The MPPT technology contains only natural, non-toxic ingredients that can return directly to natural biological cycles. Packaging is reduced to a minimum and all packaging is recyclable and, where possible, recycled. No plastics or silicones are required in the clinical procedures surrounding MPPT’s use, either.
Due to the ease of use and the rapid healing, it is ideal for self-care and facilitates inclusion of the patient in the care decisions. For those same reasons, the technology has proved ideal for use in telemedicine. This strongly promotes equality. It also supports patients’ independence, including no dependence on the availability and schedule of a nurse for help with wound dressing changes.
Willingsford is strongly involved in environmental sustainability.
Microbes are at the bottom, and therefore at the beginning, of all and every food chain and form the basis upon which all ecosystems are built – on land and in the oceans. Antimicrobials, which currently remain the standard of care in infected wounds, kill all microbes and consequently destroy habitats and ecosystems at their very root. This severely reduces biodiversity – at the microbial level and through to the very top of the chain. By not making use of antimicrobials at any point in the treatment of infected wounds, Willingsford’s technology contributes considerably to the conservation and restoration of biodiversity.
The soil and the oceans are the biggest CO2 absorbers, or “carbon-sinks”. Within the soil and oceans, the microbes are fundamental and indispensable facilitators of the absorption and storage. Killing and changing these microbial communities with antimicrobials comprehensively disrupts their capacity for uptake and storage of greenhouse gases.
Antimicrobials have not been demonstrated effective in wound infections, nor wound healing. Nevertheless, every year tens of thousands of tonnes of antimicrobials are used in wounds and disposed of with the majority escaping into the soil and waterways. Willingsford’s MPP-Technology can eliminate this use.